Based on our collective results, we conclude that miR-6794-3p modulates tumor growth via regulation of RBBP4/GRHL2 signaling, and has considerable value as a potential biomarker of metastasis in pancreatic cancer (Figure 8). Here, RBBP4 is linked to pancreatic neoplasm.